- Home
- OPFI vs ME Comparison
OPFI vs ME Comparison
Compare OPFI & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPFI
- ME
- Stock Information
- Founded
- OPFI 2009
- ME 2006
- Country
- OPFI United States
- ME United States
- Employees
- OPFI N/A
- ME N/A
- Industry
- OPFI Finance: Consumer Services
- ME Precision Instruments
- Sector
- OPFI Finance
- ME Health Care
- Exchange
- OPFI Nasdaq
- ME Nasdaq
- Market Cap
- OPFI 138.6M
- ME 113.9M
- IPO Year
- OPFI N/A
- ME N/A
- Fundamental
- Price
- OPFI $7.60
- ME $3.11
- Analyst Decision
- OPFI Buy
- ME Hold
- Analyst Count
- OPFI 2
- ME 1
- Target Price
- OPFI $6.50
- ME $9.40
- AVG Volume (30 Days)
- OPFI 489.4K
- ME 431.9K
- Earning Date
- OPFI 11-07-2024
- ME 11-12-2024
- Dividend Yield
- OPFI N/A
- ME N/A
- EPS Growth
- OPFI 775.86
- ME N/A
- EPS
- OPFI 0.38
- ME N/A
- Revenue
- OPFI $260,661,000.00
- ME $193,260,000.00
- Revenue This Year
- OPFI N/A
- ME $21.93
- Revenue Next Year
- OPFI $5.38
- ME $17.31
- P/E Ratio
- OPFI $20.13
- ME N/A
- Revenue Growth
- OPFI 23.85
- ME N/A
- 52 Week Low
- OPFI $2.35
- ME $2.66
- 52 Week High
- OPFI $7.61
- ME $20.40
- Technical
- Relative Strength Index (RSI)
- OPFI 74.04
- ME 30.62
- Support Level
- OPFI $6.73
- ME $2.66
- Resistance Level
- OPFI $7.29
- ME $3.58
- Average True Range (ATR)
- OPFI 0.44
- ME 0.45
- MACD
- OPFI 0.10
- ME -0.08
- Stochastic Oscillator
- OPFI 99.64
- ME 16.90
About OPFI OppFi Inc.
OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.